Tadalafil at a daily dose of 5 mg is an FDA-approved treatment for the urinary symptoms caused by an enlarged prostate, and it works by relaxing smooth muscle in the prostate, bladder, and surrounding blood vessels. Originally known as a medication for erectile dysfunction, it turned out to address two problems at once for men who have both conditions. The science behind why it helps with urination is more complex than most patients realize, and the clinical results show a genuine but modest improvement that starts faster than many people expect.
Why a Drug for Erections Helps with Urination
An enlarged prostate does not cause urinary symptoms through size alone. Several overlapping processes contribute: the smooth muscle in the prostate and bladder neck tightens, blood flow to the pelvic organs decreases, and nerve signaling becomes overactive. These problems share a common thread with erectile dysfunction, which is why researchers noticed decades ago that the two conditions travel together so frequently.
Tadalafil belongs to a class of drugs that block an enzyme called PDE5. When that enzyme is inhibited, a signaling molecule called cGMP accumulates in smooth muscle cells, causing them to relax. Lab studies have shown this relaxation effect in human tissue strips from the prostate, bladder, and the small arteries that supply the lower urinary tract.1PubMed. The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia That relaxation does two things at once: it eases the physical squeeze that a tight prostate puts on the urethra, and it opens up blood vessels so oxygen-starved pelvic tissues get better perfusion.
The blood flow angle turns out to matter more than it first sounds. Chronic low-grade ischemia in the bladder can make the bladder muscle hyperactive, leading to urgency, frequency, and nighttime trips to the bathroom. Animal studies have demonstrated that tadalafil protects bladder function and structure under conditions of chronic ischemia, reducing the overactivity that develops when blood supply is choked off.2PubMed. Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia More recent research has shown tadalafil promotes the growth of new small blood vessels in the pelvis and restores normal bladder perfusion in animal models of metabolic syndrome.3PubMed Central. Tadalafil Ameliorates Chronic Ischemia-Associated Bladder Overactivity in Fructose-Fed Rats by Exerting Pelvic Angiogenesis and Enhancing p-eNOS Expression
Beyond smooth muscle relaxation and improved blood flow, tadalafil also appears to calm overactive autonomic nerves in the pelvis and dial down a separate tightening pathway involving a protein called Rho-kinase.4PubMed. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action In short, the drug does not act through a single switch. It influences several of the biological routes that connect an aging prostate to bothersome urinary symptoms, which helps explain why it is effective even though it does not shrink the gland itself.
How Much Improvement to Realistically Expect
The standard way researchers measure BPH symptom severity is a questionnaire called the International Prostate Symptom Score, which runs from 0 (no symptoms) to 35 (severe). In a large international trial, men taking 5 mg of tadalafil daily for 12 weeks saw their score drop by about 5.3 points on average, compared with a 3.5-point drop in men taking a placebo.5PubMed. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial That gap of roughly two points over placebo is consistent across multiple confirmatory studies.6PubMed. Tadalafil – a therapeutic option in the management of BPH-LUTS
Two points on a 35-point scale sounds small on paper. In practice, it often translates to one or two fewer nighttime bathroom trips, less urgency during the day, or a noticeably stronger stream. The difference between “waking up three times” and “waking up once” is enormous for quality of life, even if the numerical score change looks modest.
Urinary flow rate also improves, though the evidence here is a bit mixed. A pooled analysis from clinical trials found tadalafil 5 mg increased peak flow by a median of about 1.1 mL per second more than placebo.7PubMed. Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia An earlier dose-ranging study showed flow improvements with tadalafil that were numerically better than placebo but did not quite reach statistical significance.8PubMed. Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment A year-long urodynamic study, however, found a more robust increase of about 2.9 mL per second and a meaningful decrease in the degree of bladder outlet obstruction, suggesting that longer treatment may produce better objective results.9PubMed. Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic study
How Quickly It Kicks In
One of the more encouraging findings is the speed of onset. A pooled analysis of four large placebo-controlled trials found that roughly half to 60 percent of men who ultimately responded to tadalafil had already reached a meaningful level of improvement by the end of the first week. By week four, about three-quarters of eventual responders were there.10PubMed. Time to onset of clinically meaningful improvement with tadalafil 5 mg once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: analysis of data pooled from 4 pivotal, double-blind, placebo controlled studies That timeline is comparable to alpha-blockers like tamsulosin, which are often considered the fastest-acting BPH medications. If you have not noticed any change after a month of daily use, the drug is less likely to deliver the relief you are looking for.
How It Compares to Tamsulosin
Tamsulosin is the most commonly prescribed alpha-blocker for BPH symptoms. A head-to-head randomized trial found that tadalafil and tamsulosin produced “significant and numerically similar” improvements in symptom scores and peak urinary flow compared with placebo.11PubMed. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial A meta-analysis pooling several randomized trials confirmed no statistically significant difference between the two drugs on symptom scores, voiding subscores, storage subscores, quality-of-life scores, flow rate, or post-void residual volume.12PubMed Central. Comparative Effectiveness of Tadalafil versus Tamsulosin in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia: A Meta-Analysis of Randomized Controlled Trials The one area where tadalafil clearly outperformed tamsulosin was erectile function.
One smaller prospective trial did find tamsulosin slightly more effective than tadalafil for urinary symptoms alone.13PubMed Central. Tadalafil vs. tamsulosin in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a prospective, randomized study The practical takeaway is that the two drugs are in the same ballpark for urinary relief, with tadalafil carrying a clear advantage for men who also have erection difficulties. The tradeoff profile differs too: tamsulosin can cause dizziness, abnormal ejaculation, and nasal congestion, while tadalafil’s typical side effects lean toward headache, indigestion, and back pain.
When You Have Both ED and BPH
The overlap between these two conditions is strikingly common. They share several biological roots, including reduced nitric oxide signaling, chronic pelvic ischemia, and autonomic overactivity.14PubMed. Erectile dysfunction and lower urinary tract symptoms secondary to BPH For men dealing with both, tadalafil is the only approved single-pill option that addresses both at once.
A meta-analysis confirmed that daily 5 mg tadalafil significantly improved both urinary symptom scores and erectile function scores over 12 weeks compared with placebo.15PubMed. Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis A randomized trial looking at dual responders found that men on tadalafil 5 mg had about 2.8 times the odds of achieving meaningful improvement in both conditions simultaneously compared with placebo.16PubMed. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment About 40 percent of men on tadalafil hit that dual-response threshold, versus 18 percent on placebo. That means tadalafil does not guarantee improvement in both areas for everyone, but it roughly doubles your chances of a combined win.
A separate trial comparing the 2.5 mg and 5 mg doses confirmed that the 5 mg dose is the one that moves the needle on urinary symptoms. The lower dose improved erections but did not significantly improve symptom scores.17The Journal of Sexual Medicine. Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study This is why 5 mg daily became the approved dose for BPH.
Combining Tadalafil with Other BPH Medications
For men whose symptoms are not adequately controlled by one drug, combining tadalafil with an alpha-blocker or a 5-alpha-reductase inhibitor is an option that has been studied in several trials.
With Tamsulosin
Adding tadalafil to tamsulosin appears to help with voiding symptoms specifically. A prospective trial found that the combination produced a significant drop in voiding-related symptom scores that tadalafil alone did not achieve, along with better peak flow rates.18PubMed Central. Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial A meta-analysis of the combination versus tamsulosin alone found significant improvements in total symptom scores, quality of life, flow rate, and erectile function, with comparable rates of side-effect-related dropouts between the groups, though the combination group did report more pain-related side effects.19PubMed Central. A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate Hyperplasia Another randomized trial comparing tamsulosin alone, tadalafil alone, and the combination found that all three groups improved significantly, with the combination yielding the best results on most measures.20PubMed. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia
With Finasteride
Finasteride shrinks the prostate over months by blocking the hormone that drives its growth. Adding tadalafil to finasteride improved symptom scores more than finasteride with placebo at all measured time points over 26 weeks.21PubMed. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia This combination has a particular appeal because finasteride is well known to cause sexual side effects in some men, and tadalafil can counteract those. Reviews of the evidence describe the combination as safe and well tolerated, with tadalafil reducing the sexual adverse events that 5-alpha-reductase inhibitors are known for.22PubMed Central. Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia The ideal candidate for this combination is generally a man with a prostate larger than about 30 grams who wants the long-term shrinkage benefit of finasteride without the sexual downsides.23PubMed Central. Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus
Safety, Side Effects, and Who Should Not Take It
The side-effect profile of tadalafil for BPH mirrors what has been seen with the same drug at the same dose for erectile dysfunction: headache, indigestion, back pain, muscle aches, flushing, and nasal congestion are the most common complaints. No new or unexpected adverse events beyond those already known from ED studies have been recorded in BPH trials.24PubMed Central. A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction A pooled safety analysis of four multinational trials found that side-effect rates were comparable whether men were older or younger than 65, whether they had diabetes, hypertension, or cardiovascular disease, and whether they had previously used a PDE5 inhibitor. Rates were somewhat higher in men who had recently been on an alpha-blocker.25Urology. Efficacy and Safety of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Subgroup Analyses of Pooled Data From 4 Multinational, Randomized, Placebo-controlled Clinical Studies
The one absolute contraindication that every patient needs to understand is nitrate medications. If you take nitroglycerin tablets, isosorbide mononitrate or dinitrate, or any other organic nitrate for chest pain, you cannot use tadalafil. The combination can cause a dangerous and potentially fatal drop in blood pressure. Because tadalafil stays in your system longer than other drugs in its class, the interaction window is also longer: studies have shown the blood-pressure interaction with sublingual nitroglycerin persists for at least 24 hours after taking tadalafil and is gone by 48 hours.26PubMed. Time course of the interaction between tadalafil and nitrates This interaction is not theoretical or rare; it is a firm contraindication established across the entire class of PDE5 inhibitors.27PubMed. A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction
Daily Dosing Versus On-Demand Use
Tadalafil is unusual among PDE5 inhibitors because it stays active in the body for well over a day. This allows two dosing strategies: a higher dose taken as needed before sexual activity, or a lower dose taken every day. For BPH, the daily approach is the only approved regimen, and the evidence supports that choice. A study comparing 20 mg on-demand with 5 mg daily in men who had both ED and urinary symptoms found that the daily regimen produced a larger improvement in symptom scores.28PubMed. Comparison of efficacy for erectile function and lower urinary tract symptoms of tadalafil 20 mg on-demand and 5 mg once daily in patients with erectile dysfunction This makes biological sense: the urinary symptoms are present around the clock, so steady-state drug levels maintain continuous smooth muscle relaxation rather than producing occasional spikes.
Results in Older Men
There is sometimes a concern that BPH medications work less well in men over 70, whose prostates tend to be larger and whose symptoms have been progressing for longer. A real-world study specifically examining tadalafil in older men found that those 70 and above actually showed significant improvements not only in total symptom scores and quality of life, but also in both voiding and storage symptom subscores at each follow-up visit over 24 weeks.29PubMed. Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting The drug’s safety profile did not change meaningfully in this age group either, as the pooled data mentioned earlier showed similar side-effect rates above and below age 65.
Anti-Inflammatory Effects and Emerging Research
Beyond the well-established smooth-muscle and blood-flow pathways, researchers are investigating whether tadalafil has direct anti-inflammatory benefits in the prostate. Chronic low-grade inflammation is increasingly recognized as a contributor to BPH progression. Animal research has shown that tadalafil significantly reduced macrophage and T-cell infiltration in inflamed prostate tissue, along with measurably lowering several inflammatory signaling molecules.30PubMed Central. A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis A broader review of the literature confirms that PDE5 inhibitors as a class show anti-inflammatory properties in the prostate, possibly contributing to symptom improvement beyond what smooth muscle relaxation alone would explain.31PubMed Central. The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review
A recent randomized controlled trial took this a step further, examining how tadalafil affects circulating biomarkers related to endothelial health, blood vessel growth, and metabolic function. The study found dose-dependent improvements: tadalafil raised levels of an enzyme associated with healthy blood vessel function while reducing markers of endothelial damage and inflammation. It also improved lipid-related metabolic markers.32PubMed. Effects of tadalafil on endothelial, angiogenic, metabolic, and microRNA biomarker profiles in sexually active men with BPH and erectile dysfunction: a randomized controlled trial These findings are still preliminary in terms of clinical application, but they suggest tadalafil may be doing more than managing symptoms. It may be addressing some of the vascular and inflammatory processes that drive BPH progression.
Treatment Satisfaction and Practical Considerations
When patients who used tadalafil alone for both BPH and ED were compared with patients taking separate medications for each condition, the tadalafil monotherapy group reported higher treatment satisfaction, greater ease of treatment planning, and more convenience.33PubMed Central. Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations Taking one daily pill instead of juggling an alpha-blocker every morning and a separate ED medication as needed is a genuine simplification.
Cost is worth mentioning. Tadalafil lost patent exclusivity in 2018, and generic versions are widely available. Common generic BPH drugs like tamsulosin and finasteride are available for just a few dollars a month through discount pharmacy programs. Generic tadalafil is more expensive than those but substantially cheaper than the brand-name version was. If your insurer covers it for BPH, the out-of-pocket cost may be minimal. If not, shopping around at discount pharmacies or using manufacturer coupons can bring costs down considerably. For men who would otherwise need both a BPH drug and an ED drug, the math of a single generic tadalafil prescription often works out favorably.
One thing tadalafil will not do is shrink your prostate. Unlike finasteride or dutasteride, which reduce prostate volume over months, tadalafil works entirely through functional mechanisms: relaxing muscle, improving blood flow, dampening inflammation. If your prostate is large enough that volume reduction matters for long-term outcomes or to reduce the risk of urinary retention, your doctor may recommend adding a 5-alpha-reductase inhibitor. Tadalafil is a symptom manager, and a good one, but it is not a structural treatment for the gland itself.